Analysis Makes Stronger Case for Omecamtiv Mecarbil in Severe HF

(MedPage Today) -- People with severe heart failure (HF) appeared to be the ones who benefited meaningfully from omecamtiv mecarbil therapy, according to a post-hoc analysis of the GALACTIC-HF trial.
While the overall study population showed only...